ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Crown Will Offer $924m To Merge With Re
Medtech InsightAbbott announced on 6 March it received a trifecta of good news from the US Food and Drug Administration. The regulatory agency cleared Abbott’s FreeStyle Libre 2 and Freestyle Libre 3 modified cont
Medtech InsightThe burgeoning insulin pump market has weathered COVID-19 despite physician office closures and is expected to see double-digit growth by 2024. According to a new report by Meddevicetracker , the tot